Skip to content
MedsAcross

Medicine

Escitalopram 10 mg tablet

Escitalopram · Oral
Available on requestPrescription onlyUS FDAGeneric name

Escitalopram 10 mg tablet is a generic prescription medicine for oral use, made by 34 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted from 15ºC to 30ºC…

Key facts

Active ingredient (INN)
Escitalopram
Brand
Sold under the generic name
Strength
10 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets, 500 tablets and 158 more
Manufacturers
Aurobindo PharmaIndiaCiplaIndiaTorrent PharmaceuticalsIndiaJubilant Cadista PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaAccord HealthcareIndiaExelan PharmaceuticalsAmneal PharmaceuticalsAmneal Pharmaceuticals of New YorkAscent Pharmaceuticals34 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted from 15ºC to 30ºC (59ºF to 86ºF).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06AB10 Escitalopram
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 March 2012
Identifiers
RxCUI 349332, 351249, 351250DailyMed set ID 64de12e0-c35f-4082-b902-ddbaee8158a6, ccbe97b5-da68-4fff-929a-240dd705fe6f, 85fbcce8-a870-4f04-8a0e-a12e46eed3cf +37NDC 71335-3094, 16571-756, 42708-077 +37Application ANDA078777, ANDA090432, ANDA215177 +7

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 34 labelers. The register lists 161 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle16729-169-01Accord HealthcareIndia19 March 2013
1000 tablet, film coated in 1 bottle16729-169-17Accord HealthcareIndia12 November 2013
100 tablet, film coated in 1 bottle65862-374-01Aurobindo PharmaIndia11 September 2012
500 tablet, film coated in 1 bottle65862-374-05Aurobindo PharmaIndia11 September 2012
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack65862-374-10Aurobindo PharmaIndia11 September 2012
30 tablet, film coated in 1 bottle65862-374-30Aurobindo PharmaIndia11 September 2012
5000 tablet, film coated in 1 bottle65862-374-59Aurobindo PharmaIndia11 September 2012
90 tablet, film coated in 1 bottle65862-374-90Aurobindo PharmaIndia11 September 2012
30 tablet, film coated in 1 bottle69097-848-02CiplaIndia16 June 2016
90 tablet, film coated in 1 bottle69097-848-05CiplaIndia16 June 2016
100 tablet, film coated in 1 bottle69097-848-07CiplaIndia16 June 2016
500 tablet, film coated in 1 bottle69097-848-12CiplaIndia16 June 2016
1000 tablet, film coated in 1 bottle69097-848-15CiplaIndia16 June 2016
100 tablet, film coated in 1 bottle59746-280-01Jubilant Cadista PharmaceuticalsIndia1 January 2024
500 tablet, film coated in 1 bottle59746-280-05Jubilant Cadista PharmaceuticalsIndia1 January 2024
1000 tablet, film coated in 1 bottle59746-280-10Jubilant Cadista PharmaceuticalsIndia1 January 2024
30 tablet, film coated in 1 bottle59746-280-30Jubilant Cadista PharmaceuticalsIndia1 January 2024
100 tablet, film coated in 1 bottle33342-037-11Macleods PharmaceuticalsIndia11 September 2012
100 tablet, film coated in 1 carton33342-037-12Macleods PharmaceuticalsIndia11 September 2012
500 tablet, film coated in 1 bottle33342-037-15Macleods PharmaceuticalsIndia9 September 2015
100 tablet, film coated in 1 bottle13668-136-01Torrent PharmaceuticalsIndia11 September 2012
500 tablet, film coated in 1 bottle13668-136-05Torrent PharmaceuticalsIndia11 September 2012
1000 tablet, film coated in 1 bottle13668-136-10Torrent PharmaceuticalsIndia11 September 2012
30 tablet, film coated in 1 bottle13668-136-30Torrent PharmaceuticalsIndia11 September 2012
3000 tablet, film coated in 1 bottle13668-136-43Torrent PharmaceuticalsIndia11 September 2012
30 tablet, film coated in 1 bottle65162-020-03Amneal Pharmaceuticals17 May 2017
90 tablet, film coated in 1 bottle65162-020-09Amneal Pharmaceuticals17 May 2017
1000 tablet, film coated in 1 bottle65162-020-11Amneal Pharmaceuticals17 May 2017
500 tablet, film coated in 1 bottle65162-020-50Amneal Pharmaceuticals17 May 2017
500 tablet, film coated in 1 bottle53746-020-05Amneal Pharmaceuticals of New York17 May 2017
1000 tablet, film coated in 1 bottle53746-020-10Amneal Pharmaceuticals of New York17 May 2017
30 tablet, film coated in 1 bottle53746-020-30Amneal Pharmaceuticals of New York17 May 2017
90 tablet, film coated in 1 bottle53746-020-90Amneal Pharmaceuticals of New York17 May 2017
1000 tablet in 1 bottle43602-474-10Ascent Pharmaceuticals15 July 2025
30 tablet in 1 bottle43602-474-30Ascent Pharmaceuticals15 July 2025
100 tablet, film coated in 1 bottle76282-250-01Exelan Pharmaceuticals1 October 2012
500 tablet, film coated in 1 bottle76282-250-05Exelan Pharmaceuticals1 October 2012
1000 tablet, film coated in 1 bottle76282-250-10Exelan Pharmaceuticals1 October 2012
30 tablet, film coated in 1 bottle76282-250-30Exelan Pharmaceuticals1 October 2012
90 tablet, film coated in 1 bottle76282-250-90Exelan Pharmaceuticals1 October 2012

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 August 2002Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Escitalopram 10 mg tablet.

Compare 1

Other strengths and forms of Escitalopram

Clinical summary

Escitalopram is a serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older, among other approved uses. MedsAcross supplies Escitalopram for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Escitalopram

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Escitalopram 10 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.